GSK : announces positive results from phase III severe asthma trials of depemokimab - Form 6-K
A1901p UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
Safety Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Safety Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Safety Trial Today - Breaking & Trending Today
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
BOSTON, Nov. 09, 2023 -- HilleVax, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended...
Source: marketscreener.com
Bexagliflozin (Brenzavvy): Advancing Diabetes Management With SGLT-2 Inhibition
Beyond its primary role in diabetes treatment, SGLT-2 inhibitors have demonstrated versatility in various health aspects, offering benefits beyond glucose reduction.
Source: pharmacytimes.com
Bath scientists develop 3D-printed artificial knee
Five patients undergo the fitting of the implant, designed to preserve the patient's own knee joint.
Source: yahoo.com
Vistagen to Present Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting
Late-breaking poster presentation highlights long-term, open-label treatment data of as-needed intranasal administrations of fasedienol in real-world setting ... | May 30, 2023
Source: marketscreener.com